Healthcare Bioconvergence Market Size, Share and Growth Forecast to 2030

1. 1 Healthcare Bioconvergence Market Size, Share and Growth Forecast to 2030 1 © Prescient & Strategic Intelligence Private Limited. All rights reserved

2. 2 The healthcare bioconvergence market will power at a rate of 7.5% rate by the end of this decade, to touch USD 216 billion by 2030.The industry is growing due to the growing count of elderly people and the growing usage of stem cells for regenerating organs, tissues, and injured cells. Moreover, the preference of users for combinations of cutting-edge technologies, including ML, ergonomics, robotics, and AI, with cloud computing and biology, will contribute in the direction of the industry expansion in the years to come. The drug discovery category led the industry with a share of about 22%, in the past, on the basis of the application segment, due to the growing burden of cancer, cardiovascular, and CNS-related ailments, growing costs of medical treatments, and the patent expiry of numerous medications. As per the numerous records of the government, in the U.S., about 1.9 million new cancer cases were recorded and about 609,360 deaths happened by it in 2022. Furthermore, the growing elderly populace, suffering from numerous diseases, raises the requirement for drug discoveries, which fuels the development of the industry. Also, pioneering engineering solutions are needed to streamline and hasten the expansion of new and cutting-edge drugs and lower the prices of the complete procedure, to, eventually, offer fast and accurate care. The regenerative medicine will have the fastest growth about 8%, in the years to come, credited to the capability of such treatments to treat or replace injured tissues, cells, and organs that have suffered trauma or deformed because of age related disorders. Pharma and biotech corporations are growing rapidly, credited to the rapidly growing count of clinical trials and the mounting acceptance of cutting-edge methods by them for the development of drugs. Key Players in Healthcare Bioconvergence Market Are: •Signota Solutions •BICO - The Bio Convergence Company •Merck KGaA •BioConvergent Health •Azapharm These corporations are aiming to transport medicines quicker, more competently, and at reduced costs, accompanied by concentrating on their safety for patients. Furthermore, widespread research is conducted on mRNA’s pertinence in treating non-communicable ailments, for example cancer. 2 © Prescient & Strategic Intelligence Private Limited. All rights reserved

3. 3 Europe leads the healthcare bioconvergence market, and this will be the case till the end of this decade, with USD 73 billion. The industry is growing credited to the existence of important research organizations, hospitals and medical centers. For example, in 2021 February, a U.K.- based medical research firm, LifeArc, reinforced the work of the Gen OMICC COVID-19 will be announcing funding at a value of USD 5.74 million. It is because of the growing usage for stem cells for regenerating injured tissues, cells, and organs all over the world, the demand for healthcare bioconvergence is on the rise. This trend will also continue in the years to come as well. Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ Click Here to Download a Sample Report Healthcare Bioconvergence Market Segmentation By Application •Drug Discovery •Nanorobotics for drug delivery •Regenerative medicine •Diagnostic and biological sensors •Bioelectronics •Engineered Living Materials •Optogenetics •Precision Medicine By End User •Pharmaceutical & Biotechnology Companies •Contract Research Organization (CRO) •Others By Region •North America Healthcare Bioconvergence Market oBy application oBy end user oBy country – U.S. and Canada •Europe Healthcare Bioconvergence Market oBy application oBy end user 3 © Prescient & Strategic Intelligence Private Limited. All rights reserved

4. 4 oBy country – Germany, U.K., France, Italy, Spain, and Rest of Europe •Asia-Pacific (APAC) Healthcare Bioconvergence Market oBy application oBy end user oBy country – Japan, China, India, South Korea, Australia, and Rest of APAC •Latin America (LATAM) Healthcare Bioconvergence Market oBy application oBy end user oBy country – Brazil, Mexico and Rest of LATAM •Middle East and Africa (MEA) Healthcare Bioconvergence Market oBy application oBy end user oBy country – Saudi Arabia, South Africa, U.A.E., and Rest of MEA 4 © Prescient & Strategic Intelligence Private Limited. All rights reserved

5. 5 Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 4 ©P&SIntelligence.Allrightsreserved 5 © Prescient & Strategic Intelligence Private Limited. All rights reserved